These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 147324)

  • 1. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
    Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
    J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
    Engel AG; Lambert EH; Howard FM
    Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G; Engel AG; Lindstrom J
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunopathology of acquired myasthenia gravis.
    Engel AG; Sahashi K; Fumagalli G
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
    Sahashi K; Engel AG; Lambert EH; Howard FM
    J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural study of neuromuscular junctions in experimental autoimmune myasthenia gravis (EAMG) in rabbits.
    Arizono N; Takeoka O; Hasegawa M; Yonezawa T; Yamaguchi K
    Acta Pathol Jpn; 1985 May; 35(3):621-9. PubMed ID: 4036600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
    Lennon VA; Seybold ME; Lindstrom JM; Cochrane C; Ulevitch R
    J Exp Med; 1978 Apr; 147(4):973-83. PubMed ID: 206648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
    Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
    Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
    Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
    J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG; Lambert EH
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
    Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
    J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
    Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
    Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.